Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference

Rhea-AI Summary

Yield10 Bioscience (Nasdaq: YTEN) announced that its President and CEO, Oliver Peoples, Ph.D., will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference, taking place from May 23-26, 2022, at the Fontainebleau Hotel in Miami Beach, FL. The presentation will be available on demand starting at 7:00 am ET on May 24 through May 26. Yield10 focuses on agricultural bioscience, aiming to develop improved Camelina varieties for renewable diesel, bioplastics, and omega-3 oils. More information is available on their website.

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL.

Event: H.C. Wainwright Global Hybrid Investment Conference
Time: Available on demand as of 7:00 am ET May 24 through May 26, 2022
Webcast: Click this link to view the presentation

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils for renewable diesel, PHA bioplastics and omega-3 (DHA+EPA) oils, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the Company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

(YTEN-G)

Contacts:

Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

FAQ

What is the date of the H.C. Wainwright Global Hybrid Investment Conference for Yield10 Bioscience?

The H.C. Wainwright Global Hybrid Investment Conference is scheduled from May 23 to May 26, 2022.

Who will present at the H.C. Wainwright conference for Yield10 Bioscience?

Oliver Peoples, Ph.D., President and CEO of Yield10 Bioscience, will present at the conference.

When will Yield10's presentation be available on demand?

The presentation will be available on demand from 7:00 am ET on May 24 through May 26, 2022.

What is Yield10 Bioscience's focus area?

Yield10 Bioscience focuses on agricultural bioscience, developing improved Camelina varieties for renewable applications.

Where is Yield10 Bioscience headquartered?

Yield10 Bioscience is headquartered in Woburn, Massachusetts.